Cargando…
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity
Mithramycin (MTM), a natural product of soil bacteria from the Streptomyces genus, displays potent anticancer activity but has been limited clinically by severe side effects and toxicities. Engineering of the MTM biosynthetic pathway has produced the 3-side-chain-modified analogs MTM SK (SK) and MTM...
Autores principales: | Scott, Daniel, Rohr, Jürgen, Bae, Younsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218587/ https://www.ncbi.nlm.nih.gov/pubmed/22114504 http://dx.doi.org/10.2147/IJN.S25427 |
Ejemplares similares
-
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021) -
Amorphous Nanoparticulate Formulation of Sirolimus and Its Tablets
por: Shen, Yudong, et al.
Publicado: (2018) -
Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma
por: Tornin, Juan, et al.
Publicado: (2016) -
Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1
por: Hou, Caixia, et al.
Publicado: (2016) -
Development of Nanoparticulate Formulations with Biomedical Applications Related to Cancer
por: Soica, Codruta Marinela
Publicado: (2019)